Search research articles
Contact Us
Filters
Showing results (421-430 of 477) with videos related to
Page
of 48
Sort By:
Arthritis and Rheumatism
|
February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study
Dinesh Khanna, Philip J Clements, Daniel E Furst, et al.
Arthritis and Rheumatism
|
June 3, 2008
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Kenneth G Saag, Gim Gee Teng, Nivedita M Patkar, et al.
Blood
|
April 25, 2007
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
Richard A Nash, Peter A McSweeney, Leslie J Crofford, et al.
Journal of Scleroderma and Related Disorders
|
May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'
Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
Arthritis Care & Research
|
June 18, 2023
Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings
Ivan Foeldvari, Kathryn S Torok, Jordi Anton, et al.
Arthritis and Rheumatism
|
September 5, 2002
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study
Daniel E Furst, Kenneth Saag, M Roy Fleischmann, et al.
The Journal of Rheumatology
|
October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)
Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Lancet (London, England)
|
May 10, 2016
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna, Christopher P Denton, Angelika Jahreis, et al.
Clinical and Translational Science
|
January 27, 2021
Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects
Kyung-Sang Yu, In-Jin Jang, Hyeong-Seok Lim, et al.
Arthritis and Rheumatism
|
June 10, 2010
A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis
Wenfeng Tan, Hui Wu, Jian Zhao, et al.
Page
of 48
Search research articles
Search
Showing results (421-430 of 477) with videos related to
Sort By:
Page
of 48
Arthritis and Rheumatism
|
February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study
Dinesh Khanna, Philip J Clements, Daniel E Furst, et al.
Arthritis and Rheumatism
|
June 3, 2008
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Kenneth G Saag, Gim Gee Teng, Nivedita M Patkar, et al.
Blood
|
April 25, 2007
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
Richard A Nash, Peter A McSweeney, Leslie J Crofford, et al.
Journal of Scleroderma and Related Disorders
|
May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'
Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
Arthritis Care & Research
|
June 18, 2023
Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings
Ivan Foeldvari, Kathryn S Torok, Jordi Anton, et al.
Arthritis and Rheumatism
|
September 5, 2002
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study
Daniel E Furst, Kenneth Saag, M Roy Fleischmann, et al.
The Journal of Rheumatology
|
October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)
Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Lancet (London, England)
|
May 10, 2016
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna, Christopher P Denton, Angelika Jahreis, et al.
Clinical and Translational Science
|
January 27, 2021
Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects
Kyung-Sang Yu, In-Jin Jang, Hyeong-Seok Lim, et al.
Arthritis and Rheumatism
|
June 10, 2010
A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis
Wenfeng Tan, Hui Wu, Jian Zhao, et al.
Page
of 48